Back to Search
Start Over
Diffuse alveolar hemorrhage associated with low molecular weight heparin and dual anti-platelet therapy after percutaneous coronary intervention
- Source :
- The Clinical Respiratory Journal. 11:1071-1073
- Publication Year :
- 2016
- Publisher :
- Wiley, 2016.
-
Abstract
- A 54-year-old man underwent percutaneous coronary intervention (PCI) and two stents were placed on left anterior coronary artery and circumflex artery. Low molecular weight heparin (LMWH) together with ticagrelor 90 mg twice a day and acetylsalicylic acid (Aspirin) were started after PCI due to high risk of stent thrombosis. On the fourth day of patient's follow-up in the intensive care unit (ICU), bloody secretion was started from endotracheal tube. Hemoglobin dropping, bilateral infiltration on the chest X-ray and bleeding from lung were diagnosed as diffuse alveolar hemorrhage (DAH). Apart from LMWH and antiplatelet therapies with aspirin and ticagrelor, there were no other identified risk factors for DAH. As far as we know, our report is the first case of DAH caused by LMWH and dual anti-platelet therapy including ticagrelor.
- Subjects :
- Pulmonary and Respiratory Medicine
Aspirin
medicine.medical_specialty
business.industry
medicine.drug_class
medicine.medical_treatment
Percutaneous coronary intervention
Low molecular weight heparin
Diffuse alveolar hemorrhage
030204 cardiovascular system & hematology
medicine.disease
Thrombosis
Surgery
03 medical and health sciences
0302 clinical medicine
030228 respiratory system
Conventional PCI
Immunology and Allergy
Medicine
Platelet aggregation inhibitor
cardiovascular diseases
business
Ticagrelor
Genetics (clinical)
medicine.drug
Subjects
Details
- ISSN :
- 17526981
- Volume :
- 11
- Database :
- OpenAIRE
- Journal :
- The Clinical Respiratory Journal
- Accession number :
- edsair.doi...........3528c7a912a4ea9afc5824cb87f6da28